What is OptimizeRx's EPS (diluted)?

OptimizeRx (OPRX) reported EPS (diluted) of -$0.03 in Q1 2026.

How has OptimizeRx's EPS (diluted) changed year-over-year?

OptimizeRx's EPS (diluted) increased by 75.0% year-over-year, from -$0.12 to -$0.03.

What is the long-term trend for OptimizeRx's EPS (diluted)?

Over 4 years (2021 to 2025), OptimizeRx's EPS (diluted) has grown at a 125.8% compound annual growth rate (CAGR), from $0.01 to $0.26.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

OptimizeRx OPRX EPS (Diluted)

Discontinued — last reported Q1 '26

EPS (Diluted) at other companies

Veeva SystemsVEEV

$1.57+14.6%

PhreesiaPHR

$0.05+171%

DoximityDOCS

$0.10-67.7%

GoodRx Holdings, Inc.GDRX

$0.00-100%

PubMaticPUBM

-$0.27-35.0%

National Research CorporationNRC

$12.50+4,708%

Other financials

Income statement

See full

Revenue$19.8M-9.5%

Gross profit$14.9M+11.9%

Operating income$396.0K+119%

Net income-$495.0K+77.5%

Balance sheet

See full

Cash & equivalents$20.2M+21.7%

Total debt$23.7M-27.7%

Total equity$129.6M+11.5%

Total assets$167.3M-0.3%

Cash flow

See full

Operating cash flow-$467.0K-112%

CapEx$21.0K-22.2%

Free cash flow-$488.0K-113%

Valuation

See full

Market cap$107.34M-54.1%

Enterprise value$110.88M-55.0%

P/E15.7×—

P/S1×-1.2×

Profitability

See full

Gross margin70%+14.1pp

Operating margin13.2%—

Net margin6.4%+3.6pp

FCF margin13.4%+4.8pp

Returns & leverage

See full

Return on equity5.6%+3.3pp

Debt / equity0.2×-0.1×

Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OptimizeRx's EPS (diluted)?: OptimizeRx (OPRX) reported EPS (diluted) of -$0.03 in Q1 2026.
How has OptimizeRx's EPS (diluted) changed year-over-year?: OptimizeRx's EPS (diluted) increased by 75.0% year-over-year, from -$0.12 to -$0.03.
What is the long-term trend for OptimizeRx's EPS (diluted)?: Over 4 years (2021 to 2025), OptimizeRx's EPS (diluted) has grown at a 125.8% compound annual growth rate (CAGR), from $0.01 to $0.26.
What does EPS (diluted) mean?: Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.